23
MICROANGIOPATHIC HEMOLYTIC ANEMIA

Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

Embed Size (px)

Citation preview

Page 1: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

MICROANGIOPATHIC HEMOLYTIC

ANEMIA

Page 2: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

MICROANGIOPATHIC HEMOLYTIC ANEMIA

•  Microangiopathic subgroup of hemolytic anemia (loss of red blood cells through destruction) caused by factors in the small blood vessels.

• Occurs when red cells are forced to squeeze through abnormally narrowed small vessels.

Page 3: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• Types of TMAs assd. with MAHA:–Thrombotic thrombocytopenic purpura.

–Hemolytic uremic syndrome.

–DIC• Other TMA syndromes can

occur with:–Pregnancy–Malignant hypertension–SLE

Page 4: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• Common Feature:–Microvascular lesion that causes mechanical injury to circulating red cells.

Page 5: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• Damage evident in peripheral blood smears in the form of red cell fragments- schistocytes, “burr cells”, “helmet cells” and “triangle cells”.

Page 6: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome
Page 7: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

HEMOLYTIC-UREMIC SYNDROME

Page 8: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

PATHOGENESIS1) Endothelial injury and activation.

2) Platelet aggregation

Both cause vascular obstruction and vasoconstriction

=> Precipitate distal ischaemia.

Page 9: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

ENDOTHELIAL INJURY & ACTIVATION

• Triggers can be :–Bacterial endotoxins–Cytotoxins–Cytokines–Viruses–Drugs–Antiendothelial antibodies–Abnormal multimers or

inhibitors of vWF

Page 10: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• Endothelial denudation exposes a potentially thrombogenic subendothelial connective tissue.

• Reduced production of PgI2 and nitric oxide enhances platelet aggregation and causes vasoconstriction.

Page 11: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• Activation of endothelial cells increased adhesivity to leukocytes thrombosis.

• Endothelial cells elaborate multimers of vWF that remain abnormally large platelet aggregation.

Page 12: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

PLATELET AGGREGATION

• With congenital or acquired loss of ADAMTS-13(a vWF cleaving metalloprotease) activity, very large vWF multimers persist in circulation and induce aggregation by activating platelet surface glycoproteins.

Page 13: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• CLASSIC(CHILDHOOD) HUS

• ADULT HUS

Page 14: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

CLASSIC HUS• 75% in children after intestinal

infection with verocytotoxin-producing E.coli.

• Verocytotoxin similar to Shiga toxin.

• Most frequently assd. with bloody diarrhoea.

• Some traced to ingestion of infected ground meat.

• One of the main causes of acute renal failure in children.

Page 15: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

PATHOGENESIS• Clearly related to Shiga-like

toxin.• Toxin causes:

–Increased adhesion of leukocytes.

–Increased endothelin production.

–Loss of endothelial nitric oxide.

–Endothelial lysis( in presence of cytokines such as TNF).

• Enhancement of both thrombosis and vasoconstriction- microangiopathy.

Page 16: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• Verocytotoxin also binds to platelets and directly activate them.

Page 17: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

CLINICAL FEATURES• Sudden onset.• Usually after a GI or influenza-

like prodromal episode.• Bleeding

manifestations(hematemesis & malena).

• Severe oliguria.• Hematuria.• Microangiopathic hemolytic

anemia.• Prominent neurological changes

in some patients.

Page 18: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

Fibrin stain showing platelet-fibrin thrombi (red) in the glomerular capillaries, characteristic of

thrombotic microangiopathic disorders.

Page 19: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

ADULT HUS• In association with infection.• In the antiphospholipid

syndrome.• As complications of

pregnancy and contraceptives.

• Assd. with vascular renal diseases.

• In patients treated with chemotherapeutic and immunosuppressive drugs.

Page 20: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• In typical(epidemic,classic,diarrhoea positive) HUS the trigger for endothelial injury and activation usually is a Shiga toxin.

• In inherited forms of atypical HUS, the cause of endothelial injury appears to be excessive, inappropriate activation of components.

Page 21: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

LAB FINDINGS• CBC

–Anemia–Thrombocytopenia–Peripheral smear checking for schistocytes, burr cells, helmet cells, spherocytes and segmented red blood cells

• LDH (elevated)• Haptoglobin (decreased)• Reticulocyte count

(appropriate)

Page 22: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

• PT/PTT (normal; differentiates from DIC)

• Stool tests–Shiga toxin, E. coli O157:H7 test

• Urine Analysis–Hematuria, casts

• LFT–Increased indirect bilirubin

• Chemistry–Creatinine, hyperkalemia (renal failure)

Page 23: Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome

THANK YOU